Eli Lilly and Johnson & Johnson are seeking label expansions for Omvoh and Tremfya, respectively, in Crohn’s disease ...

After both receiving FDA approval in UC, J&J and Eli Lilly are racing for their IL-23 inhibitors to get the green light in ...

Phase 3b trial evaluating Tremfya (guselkumab) in low body surface area plaque psoriasis found the treatment improved clearance.

The anti-IL-23 monoclonal antibody, called picankibart, was shown to clear or nearly clear all lesions after 16 weeks among 48.2% of the 82 participating Chinese patients that were classified as ...

In Gaza, children are dying while waiting for medical evacuation, UNICEF reveals Sudan’s humanitarian crisis continues to spiral as aid is blocked Attacks continue against UN peacekeepers on Blue Line ...

The United States said Monday it was "deeply concerned" about a bill, now passed by Israel's parliament, that bans the UN's Palestinian refugee agency from operating in the country and occupied ...